HFNC Versus NIV in Hypercapneic COPD Patients
NCT: NCT07854210 · RECRUITING
Brief Summary
Aim: To compare gas exchange trends, clinical outcomes, and tolerability between HFNC and NIV in COPD patients with mild-to-moderate hypercapnic respiratory failure.
Frequently Asked Questions
What is HFNC Versus NIV in Hypercapneic COPD Patients?
HFNC Versus NIV in Hypercapneic COPD Patients is a clinical trial registered under NCT07854210. Current status: RECRUITING.
What is the status of NCT07854210?
The current status of NCT07854210 (HFNC Versus NIV in Hypercapneic COPD Patients) is: RECRUITING.
When did HFNC Versus NIV in Hypercapneic COPD Patients start?
HFNC Versus NIV in Hypercapneic COPD Patients started on 2025-11-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.